Comparison of miR-124-3p and miR-16 for early diagnosis of hemorrhagic and ischemic stroke

Clinica Chimica Acta

Volumn 433, Issue , 2014, Pages 139-144

  Leung, Ling Yan ^a   Chan, Cangel Pui Yee ^a   Leung, Yuk Ki ^a   Jiang, Hui Lin ^b   Abrigo, Jill Morales ^a   Wang, De Feng ^a   Chung, Joseph Shun Hang ^c   Rainer, Timothy Hudson ^a   Graham, Colin Alexander ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diagnosis; Hemorrhagic stroke; Ischemic stroke; MicroRNA; Plasma

Indexed keywords

MICRORNA 124; MICRORNA 124 3P; MICRORNA 16; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MICRORNA; MIRN124 MICRORNA, HUMAN; MIRN16 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; ANTIBODY SPECIFICITY; APOPTOSIS; BLOOD; BRAIN; COMPARATIVE STUDY; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; STROKE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOLOGICAL MARKERS; BRAIN; BRAIN ISCHEMIA; EARLY DIAGNOSIS; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MICRORNAS; MIDDLE AGED; ORGAN SPECIFICITY; STROKE;

EID: 84897412976     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.03.007     Document Type: Article

References (37)

1. Hsia A.W., Tong D.C. New magnetic resonance imaging and computed tomography techniques for imaging of acute stroke. Curr Atheroscler Rep 2003, 5:252-29.
2. Siman R., McIntosh T., Soltesz K., Chen Z., Neumar R., Roberts V. Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol Dis 2004, 16:311-320.
3. Green A.J.E., Harvey R.J., Thompson E.J., Rossor M.N. Increased s100 beta in the cerebrospinal fluid of patients with frontotemporal dementia. Neurosci Lett 1997, 235:5-8.
4. Anderson R.E., Hansson L.O., Nilsson O., Dijlai-Merzoug R., Settergren G. High serum s100b levels for trauma patients without head injuries. Neurosurgery 2001, 48:1255-1258.
5. Lo T.M.D., Rainer T.H., Chan L.Y.S., Hjelm N.M., Cocks R.A. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000, 46:319-323.
6. Rainer T.H., Wong L.K.S., Lam W., Yuen E., et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 2003, 49:562-569.
7. Rainer T.H., Wong K.S., Lam W., Lam N.Y.L., Graham C.A., Lo Y.M.D. Comparison of plasma beta-globin DNA and s-100 protein concentrations in acute stroke. Clin Chim Acta 2007, 376:190-196.
8. Ambros V. The functions of animal microRNA. Nature 2004, 431:350-355.
9. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531.
10. Chen X., Ba Y., Ma L.J., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
11. Zanetti-Daellenbach R., Wight E., Fan A.X.C., et al. Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. Anticancer Res 2008, 28:921-925.
12. Ho A.S., Huang X., Cao H.B., et al. Circulating mir-210 as a novel hypoxia marker in pancreatic cancer. Transl Oncol 2010, 3:109-113.
13. Wang K., Zhang S.L., Marzolf B., et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 2009, 106:4402-4407.
14. Jeyaseelan K., Lim K.Y., Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008, 39:959-966.
15. Weng H.C., Shen C.S., Hirokawa G., Ji X., et al. Plasma mir-124 as a biomarker for cerebral infarction. Biomed Res 2011, 32:135-141.
16. Tan K.S., Armugam A., Sepramaniam S., et al. Expression profile of microRNAs in young stroke patients. PLoS One 2009, 4:e7689.
17. Krichevsky A.M., Sonntag K.C., Isacson O., Kosik K.S. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 2006, 24:857-864.
18. Laterza O.F., Lim L., Garrett-Engele P.W., et al. Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009, 55:1977-1983.
19. Danton G.H., Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 2003, 62:127-136.
20. Broughton B.R.S., Reutens D.C., Sobey C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40:E331-E339.
21. Cimmino A., Calin G.A., Fabbri M., et al. Mir-15 and mir-16 induce apoptosis by targeting bcl2. Proc Natl Acad Sci U S A 2005, 102:13944-13949.
22. Krutzfeldt J., Rajewsky N., Braich R., et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
23. Rivas M.A., Venturutti L., Huang Y.W., Schillaci R., Huang T.H.M., Elizalde P.V. Downregulation of the tumor-suppressor mir-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Res 2012, 14:R77.
24. Cermelli S., Ruggieri A., Marrero J.A., Ioannou G.N., Beretta L. Circulating microRNAs in patients with chronic hepatitis c and non-alcoholic fatty liver disease. PLoS One 2011, 6:e23937.
25. Special report from the national institute of neurological disorders and stroke: Classification of cerebrovascular diseases iii. Stroke 1990, 21:637-676.
26. Yushkevich P.A., Piven J., Hazlett H.C., et al. User-guided 3d active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimage 2006, 31:1116-1128.
27. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105:10513-10518.
28. Jauch E.C., Saver J.L., Adams H.P., et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013, 44:870-947.
29. Cheng L.C., Pastrana E., Tavazoie M., Doetsch F. Mir-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 2009, 12:399-408.
30. Hwang B.Y., Appelboom G., Ayer A., et al. Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage. Cerebrovasc Dis 2011, 31:211-222.
31. Brunswick A.S., Hwang B.Y., Appelboom G., Hwang R.Y., Piazza M.A., Connolly E.S. Serum biomarkers of spontaneous intracerebral hemorrhage induced secondary brain injury. J Neurol Sci 2012, 321:1-10.
32. Sairanen T., Carpen O., Karjalainen-Lindsberg M.L., et al. Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke 2001, 32:1750-1757.
33. Graham S.H., Chen J. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 2001, 21:99-109.
34. Reed J.C. Mechanisms of apoptosis. Am J Pathol 2000, 157:1415-1430.
35. An F.M., Gong B.D., Wang H., et al. Mir-15b and mir-16 regulate TNF mediated hepatocyte apoptosis via bcl2 in acute liver failure. Apoptosis 2012, 17:702-716.
36. Shen J., Wan R., Hu G.Y., et al. Mir-15b and mir-16 induce the apoptosis of rat activated pancreatic stellate cells by targeting bcl-2 in vitro. Pancreatology 2012, 12:91-99.
37. Adams H., Bendixen B.H., Kappellel L.J., et al. Classification of subtype of acute ischemic stroke-definitions for use in a multicenter clinical-trial. Stroke 1993, 24:35-41.